Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28170031 | 1.00 | MEN1 (0.48) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL31157721 | 1.00 | MEN1 (0.48) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL8107558 | 1.00 | MEN1 (0.48) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL4198829 | 1.00 | MEN1 (0.48) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL8018177 | 0.98 | MEN1 (0.50) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL8019810 | 0.98 | MEN1 (0.50) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL20129165 | 0.93 | MEN1 (0.50) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL11347726 | 0.89 | MEN1 (0.55) | MEN1KMT2ANPC1TSHRMAPK1 | |
| Triethylene Glycol SCHEMBL17421866 | 0.88 | MEN1 (0.47) | MEN1KMT2ANPC1TSHRMAPK1 | |
| SCHEMBL21624572 | 0.86 | MEN1 (0.65) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2692807-B1 | AQUEOUS COATING COMPOSITION | DAINIPPON TORYO KK (JP) | 2019-05-08 | — | — | EP | claimed |
| EP-0018884-B1 | PROCESS FOR THE PREPARATION OF TRIS(ETHER AMINES) AND SO OBTAINED TRIS(ETHER AMINES) | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1981-11-04 | — | — | EP | claimed |
| US-11866599-B2 | Ink set and printing method | DAI NIPPON TORYO CO., LTD. (JP) | 2024-01-09 | — | — | US | disclosed |
| US-11066430-B2 | Method for producing polyalkylene glycol derivative having amino group at end | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-07-20 | — | — | US | disclosed |
| US-11066430-B2 | Method for producing polyalkylene glycol derivative having amino group at end | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-07-20 | — | — | US | disclosed |
| EP-3825367-A1 | INK SET AND PRINTING METHOD | Dai Nippon Toryo Co., Ltd. (JP) | 2021-05-26 | — | — | EP | disclosed |
| US-20210147702-A1 | INK SET AND PRINTING METHOD | DAI NIPPON TORYO CO., LTD. (JP) | 2021-05-20 | — | — | US | disclosed |
| US-10847790-B2 | Functionalised electrochemically active material and method of functionalisation | NEXEON LIMITED (GB) | 2020-11-24 | — | — | US | disclosed |
| EP-3412700-B1 | COMPOUNDS | SHINETSU CHEMICAL CO (JP) | 2020-05-20 | — | — | EP | disclosed |
| EP-3412700-B1 | COMPOUNDS | SHINETSU CHEMICAL CO (JP) | 2020-05-20 | — | — | EP | disclosed |
| US-10550136-B2 | Method for producing polyalkylene glycol derivative having amino group at end | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-02-04 | — | — | US | disclosed |
| US-7259222-B2 | Having a layer, particularly a polyurea or polyureaurethane, about the core formed from a substituted cyclohexanediamine especially containing one or more cyclohexyl, cyclopenyl or methylthio groups | ACUSHNET COMPANY (US) | 2007-08-21 | — | — | US | disclosed |
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | disclosed |
| US-6949617-B2 | Golf balls comprising chiral diols or chiral cyclic ethers | ACUSHNET COMPANY (US) | 2005-09-27 | — | — | US | disclosed |
| US-6943213-B2 | Polyalkylacrylate compounds for use in golf balls | ACUSHNET COMPANY (US) | 2005-09-13 | — | — | US | disclosed |
| US-20050119451-A1 | Compositions for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-06-02 | — | — | US | disclosed |
| US-20050038190-A1 | Polyalkylacrylate compounds for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-02-17 | — | — | US | disclosed |
| US-20040225100-A1 | Golf balls comprising chiral diols or chiral cyclic ethers | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-11 | — | — | US | disclosed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-4343732-A | HEAT AND WEATHER RESISTANCE, BISPHENOL PHOSPHATE STABILIZER | AJINOMOTO COMPANY INCORPORATED (JP) | 1982-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066430-B2 | Method for producing polyalkylene glycol derivative having amino group at end | RAD1, AP3B1, RER1 | MEN1 3116/4885KMT2A 684/4885NPC1 4446/4885 |
| US-10550136-B2 | Method for producing polyalkylene glycol derivative having amino group at end | RAD1, AP3B1, RER1 | MEN1 3076/4885KMT2A 666/4885NPC1 4456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.